Investing.com - Ossur reported on Friday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Ossur announced earnings per share of $0.03 on revenue of $181M. Analysts polled by Investing.com anticipated EPS of $0.0308 on revenue of $192.47M.
Ossur shares are down 31% from the beginning of the year, still down 34.59% from its 52 week high of $46.55 set on September 15, 2021. They are under-performing the STOXX 600 which is down 13.83% from the start of the year.
Ossur follows other major Healthcare sector earnings this month
Ossur's report follows an earnings beat by Coloplast on August 17, who reported EPS of $6.14 on revenue of $5.85B, compared to forecasts EPS of $5.92 on revenue of $5.74B.
Demant had beat expectations on August 15 with second quarter EPS of $5.04 on revenue of $4.89B, compared to forecast for EPS of $4.91 on revenue of $5.02B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar